Showing results (121-130 of 251) with videos related to
Sort By:
Pageof 26
Obesity (Silver Spring, Md.)|October 16, 2025
Comparative Weight Change With Initiation and Adherence to Common Medications for Type 2 DiabetesNadia M Sneed, Sheryl L Rifas-Shiman, Joshua Petimar, et al.Vascular and Endovascular Surgery|October 23, 2020
Characteristics and Outcomes of Patients With Diabetes Mellitus Undergoing Peripheral Vascular Intervention for Infrainguinal Symptomatic Peripheral Artery DiseaseE Hope Weissler, Dennis I Narcisse, Jennifer A Rymer, et al.American Heart Journal|November 29, 2016
Comparison of visual assessment of coronary stenosis with independent quantitative coronary angiography: Findings from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trialRohan Shah, Eric Yow, William Schuyler Jones, et al.European Heart Journal|December 5, 2013
Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AFWilliam Schuyler Jones, Anne S Hellkamp, Jonathan Halperin, et al.Clinical Cardiology|August 12, 2020
The impact of chronic kidney disease on outcomes following peripheral vascular interventionDennis I Narcisse, Elizabeth Hope Weissler, Jennifer A Rymer, et al.Atherosclerosis|November 6, 2021
Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trialMarc D Samsky, Robert J Mentz, Amanda Stebbins, et al.Circulation. Cardiovascular Interventions|November 23, 2019
Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: Results From the EXSCEL TrialAnish Badjatiya, Peter Merrill, John B Buse, et al.Annals of Emergency Medicine|March 5, 2024
Development and Validation of a Natural Language Processing Model to Identify Low-Risk Pulmonary Embolism in Real Time to Facilitate Safe Outpatient ManagementKrunal D Amin, Elizabeth Hope Weissler, William Ratliff, et al.The Lancet. Diabetes & Endocrinology|May 20, 2024
Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysisMuhammad Shariq Usman, Deepak L Bhatt, Ishaque Hameed, et al.Circulation|September 21, 2014
Clinical trials in peripheral vascular disease: pipeline and trial designs: an evaluation of the ClinicalTrials.gov databaseSumeet Subherwal, Manesh R Patel, Karen Chiswell, et al.Pageof 26